<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00680927</url>
  </required_header>
  <id_info>
    <org_study_id>CMD 446</org_study_id>
    <nct_id>NCT00680927</nct_id>
  </id_info>
  <brief_title>Reveal® XT Performance Trial (XPECT)</brief_title>
  <official_title>Reveal® XT Performance Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic BRC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to quantify the accuracy of the atrial fibrillation diagnostics
      of the Reveal® XT in a clinical setting and to verify overall system performance, R-wave
      sensing performance, to obtain user feedback, from both patient and physician, and collect
      data on device safety.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is a prospective, non-randomized, multi-center international post-market study.

      The study will be conducted at 20-30 centers primarily in Europe. The study will be conducted
      at least in Germany, Austria, Switzerland, The Netherlands, and the Czech Republic. Study
      centers from Canada may also participate, depending on the timelines for regulatory approval
      and commercial release of the Reveal® XT in this region.

      It is expected that between 140 and 200 patients will be enrolled to ensure that at least 47
      patients are included to assess the first primary objective and at least 60 patients to
      assess the second primary objective.

      The primary objective is to quantify the AF detection performance of the device.

      The patient population will be assessed in two separate cohorts. The first primary objective
      is to quantify the 24-hour AF burden accuracy in patients with more than 1% AF burden.

      The second primary objective is to quantify the detection accuracy of non-arrhythmia in
      patients with 1% or less AF burden.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation Burden (AF Burden)</measure>
    <time_frame>46 hrs</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AF episode detection accuracy and AF episode duration accuracy</measure>
    <time_frame>46 hrs</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">247</enrollment>
  <condition>Atrial Fibrillation</condition>
  <condition>Risk of Cardiac Arrhythmias</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>46 hrs Holter ECG recording</intervention_name>
    <description>Maximum of 2 46 hrs external Holter ECG recordings are required.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is willing and able to provide his/her informed consent

          -  Patient has been implanted with a Reveal® XT

          -  Patient fulfills at least one of the following three additional requirements

               1. is scheduled for PV ablation or surgical rhythm control intervention, and the PV
                  ablation or surgical intervention can be deferred until study completion or

               2. has documented frequent AF or frequent symptoms attributable to AF or

               3. has undergone PV ablation within the last 6 months and still has symptoms
                  attributable to AF

        Exclusion Criteria:

          -  Patient has an implanted pacemaker or ICD

          -  Patient has persistent or permanent AF

          -  Patient is allergic to adhesive ECG electrodes

          -  The study will interfere with a therapeutic or diagnostic procedure which is planned
             or expected during the study period

          -  Patient is participating in another study that is expected to compromise the results
             of this study

          -  Patient is a minor, legally incompetent, or does not meet other local requirements for
             participation in a clinical study

          -  Patient is pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido H. Rieger, MD</last_name>
    <role>Study Director</role>
    <affiliation>Medtronic Bakken Research Center B.V.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gerhard Hindricks, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heartcenter Leipzig GmbH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LKH - Universitätskliniken</name>
      <address>
        <city>Innsbruck</city>
        <zip>A-6020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.ö. Krankenhaus der Elisabethinen Linz</name>
      <address>
        <city>Linz</city>
        <zip>4010</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Salzburger Landeskliniken</name>
      <address>
        <city>Salzburg</city>
        <zip>A-5020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>B-3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Laval</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Victoria Cardiac Arrhythmia Trials Inc.</name>
      <address>
        <city>Victoria</city>
        <zip>V8R 4R2</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facultni Nemocnice Brno</name>
      <address>
        <city>Brno</city>
        <zip>CZ-625 00</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nemocnice Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <zip>150 30</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika Kardiologie IKEM</name>
      <address>
        <city>Prague</city>
        <zip>CZ 140-21</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Bad Krozingen, Elektrophysiologie</name>
      <address>
        <city>Bad Krozingen</city>
        <zip>D-79189</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff Klinik Forschungsgesellschaft</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>D-61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Campus Mitte</name>
      <address>
        <city>Berlin</city>
        <zip>D-10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>D-53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Georg</name>
      <address>
        <city>Hamburg</city>
        <zip>D-20099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universität Leipzig Herzzentrum</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universitätsklinik Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medisch Centrum Alkmaar</name>
      <address>
        <city>Alkmaar</city>
        <zip>1815 JD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rijnland Ziekenhuis</name>
      <address>
        <city>Leiderdorp</city>
        <zip>2353 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMC Maastricht</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scientific Research Institute of Circulation Pathology</name>
      <address>
        <city>Novosibirsk</city>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Almazov Federal Heart, Blood &amp; Endocrinolgoy Centre</name>
      <address>
        <city>St-Petersburg</city>
        <zip>197341</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SsUSCH Baska Bystrica</name>
      <address>
        <city>Banska Bystrica</city>
        <zip>974 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NUSCH Bratislava a.s.</name>
      <address>
        <city>Bratislava</city>
        <zip>833 48</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
  </location_countries>
  <removed_countries>
    <country>Denmark</country>
  </removed_countries>
  <reference>
    <citation>Nergårdh A, Frick M. Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation. Heart. 2006 Sep;92(9):1244-7. Epub 2006 Mar 17.</citation>
    <PMID>16547207</PMID>
  </reference>
  <reference>
    <citation>Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li JH, Carbucicchio C, Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation. 2005 Jul 19;112(3):307-13. Epub 2005 Jul 11.</citation>
    <PMID>16009793</PMID>
  </reference>
  <reference>
    <citation>Kimman GJ, Theuns DA, Janse PA, Rivero-Ayerza M, Scholten MF, Szili-Torok T, Jordaens LJ. One-year follow-up in a prospective, randomized study comparing radiofrequency and cryoablation of arrhythmias in Koch's triangle: clinical symptoms and event recording. Europace. 2006 Aug;8(8):592-5. Epub 2006 Jun 27.</citation>
    <PMID>16803840</PMID>
  </reference>
  <reference>
    <citation>Senatore G, Stabile G, Bertaglia E, Donnici G, De Simone A, Zoppo F, Turco P, Pascotto P, Fazzari M. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2005 Mar 15;45(6):873-6.</citation>
    <PMID>15766823</PMID>
  </reference>
  <reference>
    <citation>Patten M, Maas R, Karim A, Müller HW, Simonovsky R, Meinertz T. Event-recorder monitoring in the diagnosis of atrial fibrillation in symptomatic patients: subanalysis of the SOPAT trial. J Cardiovasc Electrophysiol. 2006 Nov;17(11):1216-20. Epub 2006 Sep 20.</citation>
    <PMID>16987384</PMID>
  </reference>
  <reference>
    <citation>Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G; Prevention of Atrial Fibrillation after Cardioversion Investigators. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004 Aug;25(16):1385-94.</citation>
    <PMID>15302102</PMID>
  </reference>
  <reference>
    <citation>Kottkamp H, Tanner H, Kobza R, Schirdewahn P, Dorszewski A, Gerds-Li JH, Carbucicchio C, Piorkowski C, Hindricks G. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J Am Coll Cardiol. 2004 Aug 18;44(4):869-77.</citation>
    <PMID>15312874</PMID>
  </reference>
  <reference>
    <citation>Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004 Jan 7;43(1):47-52.</citation>
    <PMID>14715182</PMID>
  </reference>
  <reference>
    <citation>Strickberger SA, Ip J, Saksena S, Curry K, Bahnson TD, Ziegler PD. Relationship between atrial tachyarrhythmias and symptoms. Heart Rhythm. 2005 Feb;2(2):125-31.</citation>
    <PMID>15851283</PMID>
  </reference>
  <reference>
    <citation>Ziegler PD, Koehler JL, Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm. 2006 Dec;3(12):1445-52. Epub 2006 Aug 3.</citation>
    <PMID>17161787</PMID>
  </reference>
  <reference>
    <citation>Israel CW, Neubauer H, Olbrich HG, Hartung W, Treusch S, Hohnloser SH; BEATS Study Investigators. Incidence of atrial tachyarrhythmias in pacemaker patients: results from the Balanced Evaluation of Atrial Tachyarrhythmias in Stimulated patients (BEATS) study. Pacing Clin Electrophysiol. 2006 Jun;29(6):582-8.</citation>
    <PMID>16784423</PMID>
  </reference>
  <reference>
    <citation>Joshi AK, Kowey PR, Prystowsky EN, Benditt DG, Cannom DS, Pratt CM, McNamara A, Sangrigoli RM. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol. 2005 Apr 1;95(7):878-81.</citation>
    <PMID>15781022</PMID>
  </reference>
  <reference>
    <citation>Vasamreddy CR, Dalal D, Dong J, Cheng A, Spragg D, Lamiy SZ, Meininger G, Henrikson CA, Marine JE, Berger R, Calkins H. Symptomatic and asymptomatic atrial fibrillation in patients undergoing radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2006 Feb;17(2):134-9.</citation>
    <PMID>16533249</PMID>
  </reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2008</study_first_submitted>
  <study_first_submitted_qc>May 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2008</study_first_posted>
  <last_update_submitted>June 2, 2015</last_update_submitted>
  <last_update_submitted_qc>June 2, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2015</last_update_posted>
  <responsible_party>
    <name_title>Medtronic Bakken Research Center BV</name_title>
    <organization>Medtronic Bakken Research Center BV</organization>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Risk of cardiac arrhythmias</keyword>
  <keyword>Loop recorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

